Mayo Clinic Proceedings, ISSN 0025-6196, 2014, Volume 89, Issue 1, pp. 95 - 106
Abstract Drug hepatoxicity can be nonidiosyncratic (predictable), as in the case of acetaminophen, or idiosyncratic (unpredictable). This review article...
Internal Medicine | POPULATION | MEDICINE, GENERAL & INTERNAL | HEPATITIS-E VIRUS | SUSCEPTIBILITY | RESISTANCE | RISK | DYSFUNCTION | ACETAMINOPHEN HEPATOTOXICITY | FAILURE | EPIDEMIOLOGY | ORAL MEDICATIONS | Democratic People's Republic of Korea - epidemiology | Iceland - epidemiology | United States - epidemiology | Protein-Tyrosine Kinases - metabolism | Humans | Isoniazid - adverse effects | Male | Adult | Female | Dietary Supplements - adverse effects | Republic of Korea - epidemiology | Enzyme Inhibitors - adverse effects | France - epidemiology | Comorbidity | Chemical and Drug Induced Liver Injury - epidemiology | China - epidemiology | Liver Diseases - epidemiology | Clavulanic Acid - adverse effects | Fluoroquinolones - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Tumor Necrosis Factor-alpha - adverse effects | Spain - epidemiology | Amoxicillin - adverse effects | Causality | Drugs | Adverse and side effects | Hepatitis | Care and treatment | Diagnosis | Risk factors
Internal Medicine | POPULATION | MEDICINE, GENERAL & INTERNAL | HEPATITIS-E VIRUS | SUSCEPTIBILITY | RESISTANCE | RISK | DYSFUNCTION | ACETAMINOPHEN HEPATOTOXICITY | FAILURE | EPIDEMIOLOGY | ORAL MEDICATIONS | Democratic People's Republic of Korea - epidemiology | Iceland - epidemiology | United States - epidemiology | Protein-Tyrosine Kinases - metabolism | Humans | Isoniazid - adverse effects | Male | Adult | Female | Dietary Supplements - adverse effects | Republic of Korea - epidemiology | Enzyme Inhibitors - adverse effects | France - epidemiology | Comorbidity | Chemical and Drug Induced Liver Injury - epidemiology | China - epidemiology | Liver Diseases - epidemiology | Clavulanic Acid - adverse effects | Fluoroquinolones - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Tumor Necrosis Factor-alpha - adverse effects | Spain - epidemiology | Amoxicillin - adverse effects | Causality | Drugs | Adverse and side effects | Hepatitis | Care and treatment | Diagnosis | Risk factors
Journal Article
Archives of Pathology and Laboratory Medicine, ISSN 0003-9985, 07/2015, Volume 139, Issue 7, pp. 876 - 887
Context.-Drug-induced liver injury (DILI) represents a diverse set of responses following exposure to any manufactured or naturally occurring chemical...
AMOXICILLIN-CLAVULANIC ACID | MEDICINE, RESEARCH & EXPERIMENTAL | CLINICAL-FEATURES | PATHOLOGY | CLASS-II GENOTYPE | ORAL MEDICATIONS | HISTOLOGICAL FEATURES | POLYMERASE GAMMA | HYPERSENSITIVITY REACTIONS | CAUSALITY ASSESSMENT | MEDICAL LABORATORY TECHNOLOGY | FULMINANT HEPATIC-FAILURE | IMATINIB MESYLATE | Liver - pathology | Prevalence | Prognosis | Humans | Risk Factors | Chemical and Drug Induced Liver Injury - epidemiology | Chemical and Drug Induced Liver Injury - pathology | Chemical and Drug Induced Liver Injury - classification | Medicine, Herbal | Liver diseases | Drug therapy | Liver | Medicine, Botanic
AMOXICILLIN-CLAVULANIC ACID | MEDICINE, RESEARCH & EXPERIMENTAL | CLINICAL-FEATURES | PATHOLOGY | CLASS-II GENOTYPE | ORAL MEDICATIONS | HISTOLOGICAL FEATURES | POLYMERASE GAMMA | HYPERSENSITIVITY REACTIONS | CAUSALITY ASSESSMENT | MEDICAL LABORATORY TECHNOLOGY | FULMINANT HEPATIC-FAILURE | IMATINIB MESYLATE | Liver - pathology | Prevalence | Prognosis | Humans | Risk Factors | Chemical and Drug Induced Liver Injury - epidemiology | Chemical and Drug Induced Liver Injury - pathology | Chemical and Drug Induced Liver Injury - classification | Medicine, Herbal | Liver diseases | Drug therapy | Liver | Medicine, Botanic
Journal Article
Hepatology, ISSN 0270-9139, 10/2014, Volume 60, Issue 4, pp. 1399 - 1408
The Drug‐Induced Liver Injury Network (DILIN) studies hepatotoxicity caused by conventional medications as well as herbals and dietary supplements (HDS). To...
UNITED-STATES | HEAVY-METALS | ADULTS | PATTERNS | MEDICINES | OUTCOMES | HEALTH | GASTROENTEROLOGY & HEPATOLOGY | United States - epidemiology | Liver Transplantation | Prospective Studies | Humans | Middle Aged | Chemical and Drug Induced Liver Injury - mortality | Chemical and Drug Induced Liver Injury - epidemiology | Male | Incidence | Adult | Female | Aged | Retrospective Studies | Dietary Supplements - adverse effects | Chemical and Drug Induced Liver Injury - surgery | Drugs, Chinese Herbal - adverse effects | Fatalities | Liver | Rodents | Hepatology | Dietary supplements | Index Medicus | hepatotoxicity | causality assessment | transplantation | herbs
UNITED-STATES | HEAVY-METALS | ADULTS | PATTERNS | MEDICINES | OUTCOMES | HEALTH | GASTROENTEROLOGY & HEPATOLOGY | United States - epidemiology | Liver Transplantation | Prospective Studies | Humans | Middle Aged | Chemical and Drug Induced Liver Injury - mortality | Chemical and Drug Induced Liver Injury - epidemiology | Male | Incidence | Adult | Female | Aged | Retrospective Studies | Dietary Supplements - adverse effects | Chemical and Drug Induced Liver Injury - surgery | Drugs, Chinese Herbal - adverse effects | Fatalities | Liver | Rodents | Hepatology | Dietary supplements | Index Medicus | hepatotoxicity | causality assessment | transplantation | herbs
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 3/2004, Volume 38, Issue 2, pp. S44 - S48
Drug-induced hepatotoxicity is a frequent cause of liver injury. The predominant clinical presentation is acute hepatitis and/or cholestasis, although almost...
Drug induced liver injury | Hepatitis | Liver diseases | Cellular metabolism | Liver | Predisposing factors | Metabolic diseases | Physical trauma | Signatures | Hepatotoxicity | DANGER | INFECTIOUS DISEASES | MICROBIOLOGY | MECHANISMS | IMMUNOLOGY | BILIARY-CIRRHOSIS | Drug-Related Side Effects and Adverse Reactions | Humans | Risk Factors | Chemical and Drug Induced Liver Injury - epidemiology | Liver Diseases - epidemiology | Liver Diseases - physiopathology | Chemical and Drug Induced Liver Injury - physiopathology | Chemical and Drug Induced Liver Injury - etiology
Drug induced liver injury | Hepatitis | Liver diseases | Cellular metabolism | Liver | Predisposing factors | Metabolic diseases | Physical trauma | Signatures | Hepatotoxicity | DANGER | INFECTIOUS DISEASES | MICROBIOLOGY | MECHANISMS | IMMUNOLOGY | BILIARY-CIRRHOSIS | Drug-Related Side Effects and Adverse Reactions | Humans | Risk Factors | Chemical and Drug Induced Liver Injury - epidemiology | Liver Diseases - epidemiology | Liver Diseases - physiopathology | Chemical and Drug Induced Liver Injury - physiopathology | Chemical and Drug Induced Liver Injury - etiology
Journal Article
Hepatology, ISSN 0270-9139, 01/2017, Volume 65, Issue 1, pp. 363 - 373
Herbal and dietary supplements (HDS) are used increasingly both in the United States and worldwide, and HDS‐induced liver injury in the United States has...
GREEN TEA | PLANT-MATERIAL | STEROIDS | SAFETY | EXPERIENCE | HEPATOTOXICITY | GASTROENTEROLOGY & HEPATOLOGY | OXYELITE PRO | TRENDS | United States | Humans | Tea - adverse effects | Chemical and Drug Induced Liver Injury - epidemiology | Forecasting | Chemical and Drug Induced Liver Injury - diagnosis | Biomedical Research - legislation & jurisprudence | Phytotherapy - adverse effects | Jaundice - chemically induced | Decision Trees | Dietary Supplements - adverse effects | Chemical and Drug Induced Liver Injury - etiology | United States Food and Drug Administration | Liver | Rodents | Dietary supplements | Bile | Hepatitis | Liver diseases | Toxicity | Tetraethylammonium | Green tea | Hepatotoxicity | Steroid hormones | Index Medicus
GREEN TEA | PLANT-MATERIAL | STEROIDS | SAFETY | EXPERIENCE | HEPATOTOXICITY | GASTROENTEROLOGY & HEPATOLOGY | OXYELITE PRO | TRENDS | United States | Humans | Tea - adverse effects | Chemical and Drug Induced Liver Injury - epidemiology | Forecasting | Chemical and Drug Induced Liver Injury - diagnosis | Biomedical Research - legislation & jurisprudence | Phytotherapy - adverse effects | Jaundice - chemically induced | Decision Trees | Dietary Supplements - adverse effects | Chemical and Drug Induced Liver Injury - etiology | United States Food and Drug Administration | Liver | Rodents | Dietary supplements | Bile | Hepatitis | Liver diseases | Toxicity | Tetraethylammonium | Green tea | Hepatotoxicity | Steroid hormones | Index Medicus
Journal Article
Journal of Chemical Information and Modeling, ISSN 1549-9596, 10/2015, Volume 55, Issue 10, pp. 2085 - 2093
Drug-induced liver injury (DILI) has been the single most frequent cause of safety-related drug marketing withdrawals for the past 50 years. Recently, deep...
CHEMISTRY, MEDICINAL | COMPUTER SCIENCE, INTERDISCIPLINARY APPLICATIONS | NEURAL-NETWORKS | CHEMOINFORMATICS | ALGORITHM | COMPUTER SCIENCE, INFORMATION SYSTEMS | PREDICTIONS | HEPATOTOXICITY | CHEMISTRY, MULTIDISCIPLINARY | ARCHITECTURES | Algorithms | Glycine - chemistry | Models, Biological | Humans | Risk Factors | ROC Curve | Chemical and Drug Induced Liver Injury | Safety-Based Drug Withdrawals | Software - standards
CHEMISTRY, MEDICINAL | COMPUTER SCIENCE, INTERDISCIPLINARY APPLICATIONS | NEURAL-NETWORKS | CHEMOINFORMATICS | ALGORITHM | COMPUTER SCIENCE, INFORMATION SYSTEMS | PREDICTIONS | HEPATOTOXICITY | CHEMISTRY, MULTIDISCIPLINARY | ARCHITECTURES | Algorithms | Glycine - chemistry | Models, Biological | Humans | Risk Factors | ROC Curve | Chemical and Drug Induced Liver Injury | Safety-Based Drug Withdrawals | Software - standards
Journal Article
Drug Metabolism Reviews, ISSN 0360-2532, 2/2012, Volume 44, Issue 1, pp. 34 - 87
A frequent mechanism for drug-induced liver injury (DILI) is the formation of reactive metabolites that trigger hepatitis through direct toxicity or immune...
drug-induced liver injury | susceptibility | idiosyncrasy | liver | hepatotoxicity | mitochondria | mitochondrial DNA | mitochondrial permeability transition | mitochondrial dysfunction | Adverse drug reactions | hepatitis | steatosis | adverse drug reactions | PERMEABILITY TRANSITION PORE | COA DEHYDROGENASE-DEFICIENCY | ENDOPLASMIC-RETICULUM STRESS | HUMAN-IMMUNODEFICIENCY-VIRUS | ISOLATED RAT HEPATOCYTES | REVERSE-TRANSCRIPTASE INHIBITORS | HEPATITIS-C VIRUS | HEPATOCYTE PLASMA-MEMBRANE | FATTY-ACID OXIDATION | MANGANESE SUPEROXIDE-DISMUTASE | PHARMACOLOGY & PHARMACY | Liver - pathology | Fatty Liver - metabolism | Mitochondria, Liver - pathology | Reactive Oxygen Species - metabolism | Oxidation-Reduction | DNA, Mitochondrial - drug effects | Fatty Liver - pathology | Mitochondria, Liver - metabolism | Humans | Liver - metabolism | Mitochondrial Proteins - biosynthesis | Mitochondria, Liver - drug effects | Mitochondrial Proteins - drug effects | Pharmaceutical Preparations - metabolism | Chemical and Drug Induced Liver Injury - metabolism | Immune System - metabolism | Drug-Related Side Effects and Adverse Reactions | Mitochondria, Liver - ultrastructure | Cell Respiration - drug effects | Chemical and Drug Induced Liver Injury - pathology | DNA, Mitochondrial - biosynthesis | Fatty Liver - etiology | Index Medicus | Hépatology and Gastroenterology | Reactive Oxygen Species | Liver | DNA, Mitochondrial | Drug-Induced Liver Injury | Mitochondrial Proteins | Fatty Liver | Mitochondria, Liver | Life Sciences | Human health and pathology | Cell Respiration | Immune System | Pharmaceutical Preparations
drug-induced liver injury | susceptibility | idiosyncrasy | liver | hepatotoxicity | mitochondria | mitochondrial DNA | mitochondrial permeability transition | mitochondrial dysfunction | Adverse drug reactions | hepatitis | steatosis | adverse drug reactions | PERMEABILITY TRANSITION PORE | COA DEHYDROGENASE-DEFICIENCY | ENDOPLASMIC-RETICULUM STRESS | HUMAN-IMMUNODEFICIENCY-VIRUS | ISOLATED RAT HEPATOCYTES | REVERSE-TRANSCRIPTASE INHIBITORS | HEPATITIS-C VIRUS | HEPATOCYTE PLASMA-MEMBRANE | FATTY-ACID OXIDATION | MANGANESE SUPEROXIDE-DISMUTASE | PHARMACOLOGY & PHARMACY | Liver - pathology | Fatty Liver - metabolism | Mitochondria, Liver - pathology | Reactive Oxygen Species - metabolism | Oxidation-Reduction | DNA, Mitochondrial - drug effects | Fatty Liver - pathology | Mitochondria, Liver - metabolism | Humans | Liver - metabolism | Mitochondrial Proteins - biosynthesis | Mitochondria, Liver - drug effects | Mitochondrial Proteins - drug effects | Pharmaceutical Preparations - metabolism | Chemical and Drug Induced Liver Injury - metabolism | Immune System - metabolism | Drug-Related Side Effects and Adverse Reactions | Mitochondria, Liver - ultrastructure | Cell Respiration - drug effects | Chemical and Drug Induced Liver Injury - pathology | DNA, Mitochondrial - biosynthesis | Fatty Liver - etiology | Index Medicus | Hépatology and Gastroenterology | Reactive Oxygen Species | Liver | DNA, Mitochondrial | Drug-Induced Liver Injury | Mitochondrial Proteins | Fatty Liver | Mitochondria, Liver | Life Sciences | Human health and pathology | Cell Respiration | Immune System | Pharmaceutical Preparations
Journal Article
Toxicological Sciences, ISSN 1096-6080, 01/2010, Volume 115, Issue 2, pp. 307 - 321
Hepatic inflammation is a common finding during a variety of liver diseases including drug-induced liver toxicity. The inflammatory phenotype can be attributed...
Idiosyncratic liver toxicity | Immunemediated liver injury | Lymphocytes | Neutrophils | Innate immunity | Adverse drug reactions | Macrophages | Hepatotoxicity | DRUG-INDUCED HEPATOTOXICITY | SYSTEMIC-LUPUS-ERYTHEMATOSUS | VASCULAR ADHESION PROTEIN-1 | lymphocytes | immune-mediated liver injury | idiosyncratic liver toxicity | MURINE ACETAMINOPHEN HEPATOTOXICITY | NEUTROPHIL DEPLETION PROTECTS | adverse drug reactions | macrophages | innate immunity | HEPATIC ISCHEMIA-REPERFUSION | hepatotoxicity | C-INFECTED LIVER | REGULATORY T-CELLS | TOXICOLOGY | PARENCHYMAL-CELL INJURY | INFLAMMATORY RESPONSE | neutrophils | Liver - pathology | Immunity, Innate - drug effects | Humans | Neutrophils - drug effects | Neutrophils - immunology | Xenobiotics - toxicity | Chemical and Drug Induced Liver Injury - immunology | Liver - immunology | Lymphocyte Activation - immunology | Animals | Lymphocytes - immunology | Liver - drug effects | Lymphocyte Activation - drug effects | Drug-Related Side Effects and Adverse Reactions | Lymphocytes - drug effects | Macrophages - drug effects | Chemical and Drug Induced Liver Injury - pathology | Chemical and Drug Induced Liver Injury - etiology | Macrophages - immunology | Disease Models, Animal | Index Medicus | Review
Idiosyncratic liver toxicity | Immunemediated liver injury | Lymphocytes | Neutrophils | Innate immunity | Adverse drug reactions | Macrophages | Hepatotoxicity | DRUG-INDUCED HEPATOTOXICITY | SYSTEMIC-LUPUS-ERYTHEMATOSUS | VASCULAR ADHESION PROTEIN-1 | lymphocytes | immune-mediated liver injury | idiosyncratic liver toxicity | MURINE ACETAMINOPHEN HEPATOTOXICITY | NEUTROPHIL DEPLETION PROTECTS | adverse drug reactions | macrophages | innate immunity | HEPATIC ISCHEMIA-REPERFUSION | hepatotoxicity | C-INFECTED LIVER | REGULATORY T-CELLS | TOXICOLOGY | PARENCHYMAL-CELL INJURY | INFLAMMATORY RESPONSE | neutrophils | Liver - pathology | Immunity, Innate - drug effects | Humans | Neutrophils - drug effects | Neutrophils - immunology | Xenobiotics - toxicity | Chemical and Drug Induced Liver Injury - immunology | Liver - immunology | Lymphocyte Activation - immunology | Animals | Lymphocytes - immunology | Liver - drug effects | Lymphocyte Activation - drug effects | Drug-Related Side Effects and Adverse Reactions | Lymphocytes - drug effects | Macrophages - drug effects | Chemical and Drug Induced Liver Injury - pathology | Chemical and Drug Induced Liver Injury - etiology | Macrophages - immunology | Disease Models, Animal | Index Medicus | Review
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 3/2009, Volume 106, Issue 11, pp. 4402 - 4407
Drug-induced liver injury is a frequent side effect of many drugs, constitutes a significant threat to patient health and has an enormous economic impact on...
MicroRNA | Animals | Tissue samples | RNA | Liver | Overdose | Physical trauma | Biological markers | Species | Blood plasma | Plasma | ALT | Acetaminophen overdose | Toxicity | MiRNA | toxicity | DIAGNOSIS | TESTS | acetaminophen overdose | MULTIDISCIPLINARY SCIENCES | N-ACETYLCYSTEINE | CANCER | PARACETAMOL OVERDOSE | miRNA | SERUM BIOMARKERS | HEPATOTOXICITY | TISSUES | plasma | Acetaminophen - adverse effects | Liver Circulation | Drug Overdose | Humans | Biomarkers - blood | Liver - injuries | Tissue Distribution | MicroRNAs - analysis | Drug-Related Side Effects and Adverse Reactions | Liver Diseases - diagnosis | Chemical and Drug Induced Liver Injury | Mice | MicroRNAs - blood | Liver diseases | Genetic aspects | Diagnosis | Research | Health aspects | Index Medicus | Biological Sciences
MicroRNA | Animals | Tissue samples | RNA | Liver | Overdose | Physical trauma | Biological markers | Species | Blood plasma | Plasma | ALT | Acetaminophen overdose | Toxicity | MiRNA | toxicity | DIAGNOSIS | TESTS | acetaminophen overdose | MULTIDISCIPLINARY SCIENCES | N-ACETYLCYSTEINE | CANCER | PARACETAMOL OVERDOSE | miRNA | SERUM BIOMARKERS | HEPATOTOXICITY | TISSUES | plasma | Acetaminophen - adverse effects | Liver Circulation | Drug Overdose | Humans | Biomarkers - blood | Liver - injuries | Tissue Distribution | MicroRNAs - analysis | Drug-Related Side Effects and Adverse Reactions | Liver Diseases - diagnosis | Chemical and Drug Induced Liver Injury | Mice | MicroRNAs - blood | Liver diseases | Genetic aspects | Diagnosis | Research | Health aspects | Index Medicus | Biological Sciences
Journal Article
Gastroenterology, ISSN 0016-5085, 2014, Volume 146, Issue 4, pp. 914 - 928.e1
Idiosyncratic drug-induced liver injury (DILI) is a rare disease that develops independently of drug dose, route, or duration of administration. Furthermore,...
Gastroenterology and Hepatology | Side Effect | Liver Failure | Acetaminophen | Epidemiology | ACETAMINOPHEN-INDUCED HEPATOTOXICITY | GENETIC-BASIS | T-CELLS PROVIDES | ORAL MEDICATIONS | GENERAL-POPULATION | CLASS-I | TERM-FOLLOW-UP | GENOME-WIDE | GASTROENTEROLOGY & HEPATOLOGY | PHENOTYPE STANDARDIZATION | PROTEIN ADDUCTS | Predictive Value of Tests | Genetic Predisposition to Disease | Liver - pathology | Pharmacogenetics | Prognosis | Humans | Liver - metabolism | Risk Factors | Terminology as Topic | Chemical and Drug Induced Liver Injury - epidemiology | Biomarkers - blood | Chemical and Drug Induced Liver Injury - genetics | Chemical and Drug Induced Liver Injury - diagnosis | Animals | Liver - drug effects | Registries | Chemical and Drug Induced Liver Injury - blood | Chemical and Drug Induced Liver Injury - classification | Liver diseases | Metabolites | Glutamate | Liver | Genomics | Amoxicillin | Index Medicus | Abridged Index Medicus | side effect | epidemiology | liver failure
Gastroenterology and Hepatology | Side Effect | Liver Failure | Acetaminophen | Epidemiology | ACETAMINOPHEN-INDUCED HEPATOTOXICITY | GENETIC-BASIS | T-CELLS PROVIDES | ORAL MEDICATIONS | GENERAL-POPULATION | CLASS-I | TERM-FOLLOW-UP | GENOME-WIDE | GASTROENTEROLOGY & HEPATOLOGY | PHENOTYPE STANDARDIZATION | PROTEIN ADDUCTS | Predictive Value of Tests | Genetic Predisposition to Disease | Liver - pathology | Pharmacogenetics | Prognosis | Humans | Liver - metabolism | Risk Factors | Terminology as Topic | Chemical and Drug Induced Liver Injury - epidemiology | Biomarkers - blood | Chemical and Drug Induced Liver Injury - genetics | Chemical and Drug Induced Liver Injury - diagnosis | Animals | Liver - drug effects | Registries | Chemical and Drug Induced Liver Injury - blood | Chemical and Drug Induced Liver Injury - classification | Liver diseases | Metabolites | Glutamate | Liver | Genomics | Amoxicillin | Index Medicus | Abridged Index Medicus | side effect | epidemiology | liver failure
Journal Article